Challenge
A medical company was transferring European manufacturing for a biologic component across an international program. Validation work lacked a coherent documentation and approval plan, while the original plant had already closed.
Response
PMO Partners assessed gaps, exposed critical-path activities, and coordinated technical, quality, operations, and regulatory teams. The team organized design-control evidence and managed translation, auditing, and control of manufacturing records for the FDA submission.
Outcome
The filing was submitted on time and approved in six months—more than six months earlier than expected—without a facility inspection. The milestone helped maintain clinical trials and patient access while avoiding additional preparation and consulting costs.
An edited client story. Outcomes and figures describe the reported engagement, rather than a promise of results for another organization.